2026.04.02

SK bioscience Earns MSCI ESG ‘A’ Rating for Third Consecutive Year… Demonstrates ESG Competitiveness Amid Stre...

2026.03.23

SK bioscience and IDT Biologika Partner on Development and Manufacturing of Drug Product for MSD’s Zaire Ebola...

2026.03.19

SK bioscience and IVI Announce Recipients of the 2026 ManHoon Park Award, Including U.S. Professor Orenstein

2026.03.18

SK bioscience Secures Funding to Advance RSV Preventive Antibody Development with RIGHT Foundation Support

2026.03.12

SK bioscience Hosts Nationwide Forum for Healthcare Professionals to Raise Awareness of Meningococcal Disease